October 21, 2016 11:33 PM ET


Company Overview of Oxagen Limited

Company Overview

Oxagen Limited, a biopharmaceutical company, develops and commercializes anti-inflammatory medicines to treat asthma and other chronic allergic conditions. The company offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhinoconjunctivitis. Its drug programs target the CRTH2 receptor that initiates and maintains allergic conditions. The company develops a pipeline of small molecule drugs. It serves customers in the United Kingdom, the Russian Federation, CIS countries, and internationally. Oxagen Limited was incorporated in 1996 and is based in Abingdon, United Kingdom.

Innovation Centre

99 Park Drive

Milton Park

Abingdon,  OX14 4RY

United Kingdom

Founded in 1996


44 12 3584 1561


44 1235 443301

Key Executives for Oxagen Limited

Chief Executive Officer and Chief Scientific Officer
Chief Commercial Officer
Director of Investment and Expertise Department
Director of Pharmacology
Director of Discovery & Development Projects
Compensation as of Fiscal Year 2016.

Oxagen Limited Key Developments

Eleventa Ltd. and Oxagen Limited Announce Completion of Patient Enrollment in Phase 3 Clinical Trial of CRTH2 Antagonist Timapiprant for the Treatment of Allergic Asthma

Eleventa Ltd. and Oxagen Limited announced the completion of patient enrollment in the a Phase 3 clinical study of Timapiprant (formerly OC000459), for treatment of atopic eosinophilic asthma in adults. Two hundred twelve patients have been enrolled in the randomized, double-blind study in 21 centers in Russia. The main objective of the study is to assess the effect of Timapiprant on respiratory function, safety, tolerability and quality of life. The patients receive Timapiprant/placebo 50mg once daily over a treatment period of 12 weeks.

Similar Private Companies By Industry

Company Name Region
Abbey Pharma Limited Europe
Absynth Biologics Limited Europe
Acacia Pharma Limited Europe
AccentBio Ltd. Europe
Aclar Limited Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Oxagen Limited, please visit www.oxagen.co.uk. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.